This induced growth arrest and apoptosis, specifically in IDH-mutant gliomas highlighting a metabolic vulnerability characterized by elevated ceramides and decreased SPHK2 expression in IDH-mutant compared to IDH-wildtype gliomas. The gene discussed is SPHK2; the disease is glioma.